← FDA Drug Approvals (Drugs@FDA)

DOXERCALCIFEROL

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2018-11-01

Drug application

FDA Application #

ANDA210801

Application type

Abbreviated New Drug Application (Generic)

Brand name

DOXERCALCIFEROL

Generic name

Doxercalciferol

Active ingredients

DOXERCALCIFEROL

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Discontinued

Sponsor

LUPIN

First approval

2018-11-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown